Diamyd Medical AB - Class B

OSTO:DMYD B (Sweden)   Class B
kr 11.50 (-1.71%) May 14
At Loss
P/B:
6.03
Market Cap:
kr 1.09B ($ 101.27M)
Enterprise V:
kr 954.75M ($ 88.55M)
Volume:
118.68K
Avg Vol (2M):
186.70K
Also Trade In:
Volume:
118.68K
At Loss
Avg Vol (2M):
186.70K

Business Description

Description
Diamyd Medical AB is a Sweden-based company engaged in the field of pharmaceutical development. It develops therapies using in-licensed substances glutamic acid decarboxylase (GAD) and GABA for the prevention or treatment of diabetes and other inflammatory diseases. The firm is focused on finding the cure for diabetes and other serious inflammatory diseases through pharmaceutical development and investments in stem cells and medical technology. Its product portfolio consists of Diamyd, for the treatment of autoimmune diabetes; Remygen, a regenerative and immunomodulatory therapy for the treatment of autoimmune diabetes and type 2 and type 1 diabetes.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.8
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 10.48
Distress
Grey
Safe
Beneish M-Score 2.17
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
3-Year Revenue Growth Rate 11.9
3-Year Book Growth Rate 24.5
Name Current Vs Industry Vs History
5-Day RSI 65.14
9-Day RSI 60.3
14-Day RSI 56.28
6-1 Month Momentum % 34.49
12-1 Month Momentum % -33.88

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.78
Quick Ratio 7.78
Cash Ratio 6.68
Days Sales Outstanding 112.35
Days Payable 658.14

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -6.6
Shareholder Yield % -7.54

Financials (Next Earnings Date:2024-06-26)

OSTO:DMYD B's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Diamyd Medical AB Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil kr) 0.282
EPS (TTM) (kr) -1.472
Beta 1.61
Volatility % 109.02
14-Day RSI 56.28
14-Day ATR (kr) 0.753365
20-Day SMA (kr) 10.594
12-1 Month Momentum % -33.88
52-Week Range (kr) 6.41 - 20
Shares Outstanding (Mil) 94.95

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Diamyd Medical AB Filings

Filing Date Document Date Form
No Filing Data

Diamyd Medical AB Stock Events

Financials Calendars
Event Date Price(kr)
No Event Data

Diamyd Medical AB Frequently Asked Questions

What is Diamyd Medical AB(OSTO:DMYD B)'s stock price today?
The current price of OSTO:DMYD B is kr11.50. The 52 week high of OSTO:DMYD B is kr20.00 and 52 week low is kr6.41.
When is next earnings date of Diamyd Medical AB(OSTO:DMYD B)?
The next earnings date of Diamyd Medical AB(OSTO:DMYD B) is 2024-06-26.
Does Diamyd Medical AB(OSTO:DMYD B) pay dividends? If so, how much?
Diamyd Medical AB(OSTO:DMYD B) does not pay dividend.

Press Release

Subject Date
No Press Release